Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage, Joseph M. Connors, Susana Ben-Neriah, Sanja Rogic, David W. Scott, King L. Tan, Christian Steidl, Laurie H. Sehn, Wing C. Chan, Javeed Iqbal, Paul N. Meyer, Georg Lenz, George Wright, Lisa M. Rimsza, Carlo Valentino, Patrick Brunhoeber, Thomas M. Grogan, Rita M. BrazielJames R. Cook, Raymond R. Tubbs, Dennis D. Weisenburger, Elias Campo, Andreas Rosenwald, German Ott, Jan Delabie, Christina Holcroft, Elaine S. Jaffe, Louis M. Staudt, Randy D. Gascoyne

Research output: Contribution to journal › Article › peer-review

766 Scopus citations

Fingerprint

Dive into the research topics of 'Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone'. Together they form a unique fingerprint.

Medicine & Life Sciences